BA/BS degree and related exp. OL OL OL LI { Global Senior Manager of Medical Information Advanced Accelrator Applications, a Novartis Company 2017 – Present 2 years. Saint-Genis-Pouilly, Auvergne-Rhone-Alpes, France. Aetna considers lutetium Lu 177 dotatate (Lutathera) medically necessary for members with the following indications: Pheochromocytoma/paraganglioma - for treatment of somatostatin receptor-positive pheochromocytoma/paraganglioma when the member has locally unresectable disease or distant metastases. padding-bottom: 4px; Partial remote position will achieve sales forecasts/growth targets, build, lead/manage sales organization, ensure optimal allocation of resources, and lead a team of managers to develop business plans. Full-Time, Partial Remote Job Boston, MA Candidates need to be able to work in the City or State specified. Full-Time, Partial Remote Job Dallas, TX Candidates need to be able to work in the City or State specified. Home-based position. Full-time liaison needed for a full-time, partially remote position building business relationships, coordinating and analyzing data, answering inquiries, fulfilling requests, monitoring and ensuring compliance. Full-Time, Partial Remote Job Atlanta, GA Candidates need to be able to work in the City or State specified. } Kisco, New York 10549-2555914-683-1001 or 888-722-3132, Nutritional Concerns For The Carcinoid Patient, Nutrition and Diet for Carcinoid Patients, Resources for Carcinoid and NET Cancer Insurance Appeals, Medical Opinion: When to Start and How to Treat Metastatic Carcinoid, Preparing for the 24-Hour Urine 5HIAA Test, Scintigraphic Evaluation of Neuroendocrine Tumors, InterScience Institute Neuroendocrine Tumors Handbook, Neuroendocrine Tumors: A Guide for Nurses. Will create strategies, build relationships, meet sales goals, implement plans and provide industry expertise. Clinically significant tumor burden and low grade (typical) histology; Member has somatostatin receptor-positive neuroendocrine tumor of the gastrointestinal tract, lung or thymus; Member experienced progression on octreotide or lanreotide; Lutathera will be used in combination with, octreotide LAR or lanreotide for persistent symptoms (i.e., flushing, diarrhea), Neuroendocrine Tumors of the Gastrointestinal Tract, Lung and Thymus (Carcinoid Tumors) (Category 1 for progressive mid-gut tumors; 2A for all others), Consider for poorly controlled carcinoid syndrome if somatostatin receptor positive imaging and progression on octreotide/lanreotide in combination with, either octreotide LAR or lanreotide for persistent symptoms (ie. Prescribing Information. The company is headquartered in Saint-Genis-Pouilly, Auvergne-Rhône-Alpes, France, with U.S. headquarters in Millburn, New Jersey; 19 production and R&D facilities; and over 900 team members across 12 countries. ol.numberedList LI { Tumors of the gastrointestinal (GI) tract (carcinoid tumor) - for treatment of somatostatin receptor-positive NETs of the gastrointestinal tract when both of the following criteria are met: Member has clinically significant tumor burden or progressive locoregional advanced disease and/or distant metastases; Member experienced disease progression on octreotide or lanreotide; Tumors of the pancreas - for treatment of somatostatin receptor-positive NETs of the pancreas when both of the following criteria are met: Member has progressive locoregional advanced disease and/or distant metastases; Neuroendocrine tumors (NETs) of the lung and thymus (carcinoid tumors). } Full-Time, Partial Remote Job Switzerland. background: #5e9732; .newText { This special program was initiated and is sponsored by the Big Apple NETs support group,…, The clock is ticking!! Requires a PhD, MD, PharmD, or other acceptable credential. Medical science liaison oncology needed for a full-time opportunity. } Netspot (dotatate)." Bachelor's degree and related experience required. color: red!important; Aetna considers lutetium Lu 177 dotatate experimental and investigational for all other indications. 1. See full prescribing information for LUTATHERA. Remote role with overnight travel. MD required and two years of experience. The median age in the efficacy subset was 61 years (25 to 88 years), 52% were male, 61% had a baseline Karnofsky performance status ≥ 90 (60 to 100), 60% had progressed within 12 months of treatment, and 15% had received prior chemotherapy. Additionally, an Expanded…, Breaking News from Advanced Accelerator Applications (AAA) about PRRT Treatment— Advanced Accelerator Applications announced on March 23 that the company has initiated an expanded access program (EAP) in the United States for the investigational…, Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…, As we begin a new year, the Carcinoid Cancer Foundation looks back on the highlights of 2015 and to a future that we hope will bring greater awareness of carcinoid and neuroendocrine cancers, earlier diagnosis for patients, new treatment options, and …, Excel Diagnostics and Nuclear Oncology Center in Houston, Texas, is the first center in the United States to start recruiting patients in a multicenter randomized clinical trial of Lu-177 Octreotate in patients with progressive midgut carcinoid. } Lutathera (lutetium Lu 177 dotatate) is available for injection as 370 MBq/mL (10 mCi/mL) in single-dose vial. New York, NY, USA. Full-time, partially remote position. MD degree needed and to years of experience. } Full-Time, Partial Remote Job Philadelphia, PA Candidates need to be able to work in the City or State specified. Advanced Accelerator Applications (NASDAQ:AAAP), a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. In the NETTER-1 trial, Strosberg et al (2017) stated patients with advanced midgut neuroendocrine tumors who have had disease progression during first-line somatostatin analogue therapy have limited therapeutic options.

Tasmania Hobart, No Excuses!, Beirut Victims List, Dollar Store Westfield, Ma, If I Had A Heart Breaking Bad,